血红蛋白
化学
活性氧
红细胞
过氧化氢
氧气
血液替代品
膜
纳米颗粒
纳米技术
生物化学
材料科学
有机化学
作者
Michelle Maria Theresia Jansman,Clara Coll-Satue,Xiaoli Liu,Paul J. Kempen,Thomas L. Andresen,Peter W. Thulstrup,Leticia Hosta‐Rigau
出处
期刊:Biomaterials advances
[Elsevier BV]
日期:2022-02-03
卷期号:134: 112691-112691
被引量:31
标识
DOI:10.1016/j.msec.2022.112691
摘要
Despite being an indispensable clinical procedure, the transfusion of donor blood has important limitations including a short shelf-life, limited availability and specific storage requirements. Therefore, a lot of effort has been devoted to developing hemoglobin (Hb)-based oxygen carriers (HBOCs) that are able to replace or complement standard blood transfusions, especially in extreme life-threatening situations. Herein, we employed a Hb-loaded poly(lactide-co-glycolide) core which was subsequently coated with nanozymes to protect the encapsulated Hb from oxidation by reactive oxygen species. To render HBOCs with long circulation in the vasculature, which is a crucial requirement to achieve the high oxygen demands of our organism, the carrier was coated with a red blood cell-derived membrane. Three coating methods were explored and evaluated by their ability to repel the deposition of proteins and minimize their uptake by an endothelial cell line. Preservation of the oxygen carrying capacity of the membrane-coated carrier was demonstrated by an oxygen-binding and releasing assay and, the functionality resulting from the entrapped nanozymes, was shown by means of superoxide radical anion and hydrogen peroxide depletion assays. All in all, we have demonstrated the potential of the membrane-coated nanocarriers as novel oxygen carrying systems with both antioxidant and stealth properties.
科研通智能强力驱动
Strongly Powered by AbleSci AI